9:33 AM
 | 
Feb 08, 2018
 |  BC Extra  |  Politics & Policy

FDA facilitating generic versions of complex drugs

FDA released new guidance documents Thursday that are intended to facilitate generic competition for “complex,” hard-to-copy drugs. It issued product-specific guidance on 19 complex medicines, including six that have no generic competition. The drugs are considered complex to...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >